Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.
about
The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for ImmunotherapyAnimal models to improve our understanding and treatment of suicidal behaviorTryptophan catabolism and immune activation in primary and chronic HIV infectionCancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors.Kynurenine Signaling Increases DNA Polymerase Kappa Expression and Promotes Genomic Instability in Glioblastoma Cells.Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of GlioblastomaImmunomodulatory Factors Galectin-9 and Interferon-Gamma Synergize to Induce Expression of Rate-Limiting Enzymes of the Kynurenine Pathway in the Mouse Hippocampus.Biological relevance of Hsp90-binding immunophilins in cancer development and treatment.Elevated FKBP52 expression indicates a poor outcome in patients with breast cancer.IDO1 in cancer: a Gemini of immune checkpoints.Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4.Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice.An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.
P2860
Q28073631-33B2B011-70F5-4D07-8AF8-B77DAFFAF338Q33635653-629DBBCF-B812-4EDB-BF09-9EDB84889417Q33697163-8AF834EB-9B7D-4EFE-8B7F-173505C30258Q34913785-795647D7-68CC-466B-A393-09CB6464E7A5Q36479788-A30BF01B-E8EF-4251-9525-934237DBAE4CQ36952693-15E4BD21-9DC7-4213-AA63-4D5C719A7739Q37342523-963E97FD-21EF-4B78-8814-712495926764Q38371280-DD282402-B0ED-4FA3-B28B-3CC9A76B14ADQ45351560-D0BC550D-A5C3-4CF6-B13C-3B19F574D97DQ47836812-E947CCD7-DF9F-4297-B943-C38DF1D557DCQ49092861-D714D4F3-A19E-40A3-912D-78D5A0D02E6AQ53438486-26AC414A-250D-43F2-A3B3-29E02B1F4C53Q55381445-609B89B1-2A06-4600-8831-DDE089664FF6
P2860
Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Suppression of TDO-mediated tr ...... sive FKBP52-dependent pathway.
@en
type
label
Suppression of TDO-mediated tr ...... sive FKBP52-dependent pathway.
@en
prefLabel
Suppression of TDO-mediated tr ...... sive FKBP52-dependent pathway.
@en
P2093
P2860
P50
P356
P1433
P1476
Suppression of TDO-mediated tr ...... sive FKBP52-dependent pathway.
@en
P2093
Jonas Blaes
Katharina J Rauschenbach
Katharina Ochs
Martina Ott
Ulrike M Litzenburger
P2860
P356
10.1002/GLIA.22734
P50
P577
2014-08-05T00:00:00Z